Fig. 2From: High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse eventsHistograms percent of patients with equivalent dose in 2 Gy fractions (EQD2Gy) for bladder a, rectum b, sigmoid c, and CTV (d)Back to article page